mRNA vaccine manufacturing scale-up — the exponential expansion of plasmid DNA template production, in vitro transcription, lipid nanoparticle formulation, and fill-finish capacity to meet post-pandemic sustained demand for COVID-19 boosters, seasonal flu combinations, and personalized cancer vaccines representing the fastest-growing capacity driver in the global nucleic acid therapeutics...